{{Rsnum
|rsid=3794087
|Gene=SLC1A2
|Chromosome=11
|position=35308068
|Orientation=minus
|GMAF=0.2158
|Gene_s=SLC1A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 8.0 | 35.7 | 56.2
| HCB | 3.6 | 33.6 | 62.8
| JPT | 7.1 | 50.4 | 42.5
| YRI | 0.0 | 7.5 | 92.5
| ASW | 0.0 | 19.3 | 80.7
| CHB | 3.6 | 33.6 | 62.8
| CHD | 4.6 | 30.3 | 65.1
| GIH | 0.0 | 16.8 | 83.2
| LWK | 1.9 | 20.6 | 77.6
| MEX | 12.1 | 39.7 | 48.3
| MKK | 1.9 | 18.6 | 79.5
| TSI | 7.8 | 37.3 | 54.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22764253
|Title=Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor
|OA=1
}}

{{PMID Auto
|PMID=24424098
|Title=The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome
}}

{{PMID Auto
|PMID=23596072
|Title=SLC1A2 variant associated with essential tremor but not Parkinson disease in Chinese subjects.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}